{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:58:35Z","timestamp":1761929915168,"version":"3.37.3"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelings Samenwerking(VLIR-UOS), Belgium","award":["Code ZAIN2014Z168"],"award-info":[{"award-number":["Code ZAIN2014Z168"]}]},{"name":"Fonds Wetenschappelijk Onderzoek (FWO), Belgium","award":["G.078.11"],"award-info":[{"award-number":["G.078.11"]}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership (EDCTP)","doi-asserted-by":"crossref","award":["MS.2010.10800.004"],"award-info":[{"award-number":["MS.2010.10800.004"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"crossref"}]},{"name":"VLIR-UOS ICP PhD programme","award":["Scholarship"],"award-info":[{"award-number":["Scholarship"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191922","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T13:34:40Z","timestamp":1517492080000},"page":"e0191922","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9694-9293","authenticated-orcid":true,"given":"Vito","family":"Baraka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hypolite Muhindo","family":"Mavoko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Nabasumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filbert","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Lutumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Alifrangis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Van geertruyden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"ref1","unstructured":"OMS, (Organisation Mondiale de la Sant\u00e9). World malaria report 2016. 2016; 186."},{"year":"2015","key":"ref2","article-title":"Guidelines For The Treatment of Malaria"},{"key":"ref3","article-title":"Artemisinin-based combination treatment of falciparum malaria","author":"F Nosten","year":"2007","journal-title":"Artemisinin-based combination treatment of falciparum malaria"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: A multisite prospective cohort study","volume":"16","author":"C Amaratunga","year":"2016","journal-title":"Lancet Infect Dis. Lancet Publishing Group"},{"key":"ref5","first-page":"50","article-title":"A molecular marker of artemisinin-resistant <italic>Plasmodium falciparum<\/italic> malaria","volume":"505","author":"F Ariey","year":"2014","journal-title":"Nature. Nature Publishing Group, a division of Macmillan Publishers Limited"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","article-title":"Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: A cross-sectional survey of the K13 molecular marker","volume":"15","author":"M Dhorda","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref7","article-title":"Four Artemisinin-Based Treatments in African Pregnant Women with Malaria","author":"TPS Group","year":"2016","journal-title":"Four Artemisinin-Based Treatments in African Pregnant Women with Malaria"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1473-3099(16)30020-2","article-title":"Comparison of artesunate\u2013mefloquine and artemether\u2013lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial","volume":"16","author":"SB Sirima","year":"2016","journal-title":"Lancet Infect Dis"},{"volume":"284","article-title":"Nature","year":"2010","key":"ref9"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"RT Eastman","year":"2009","journal-title":"Nat Rev Microbiol. Nature Publishing Group"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.febslet.2011.04.042","article-title":"Drug-resistant malaria: Molecular mechanisms and implications for public health","author":"I Petersen","year":"2011","journal-title":"FEBS Letters"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"RN Price","year":"2004","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.meegid.2007.03.005","article-title":"Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa","volume":"7","author":"G Holmgren","year":"2007","journal-title":"Infect Genet Evol"},{"key":"ref14","article-title":"In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)","author":"C Sisowath","year":"2005","journal-title":"The Journal of infectious diseases"},{"key":"ref15","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","author":"MI Veiga","year":"2016","journal-title":"Nat Commun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.00875-06","article-title":"Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria","volume":"51","author":"GS Humphreys","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/AAC.50.5.1893-1895.2006","article-title":"Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic","volume":"50","author":"C Dokomajilar","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.03647-14","article-title":"In vivo selection of plasmodium falciparum pfcrt and pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso","volume":"59","author":"V Baraka","year":"2015","journal-title":"Antimicrob Agents Chemother. American Society for Microbiology"},{"key":"ref19","article-title":"Role of Pfmdr1 in In Vitro Plasmodium falciparum Susceptibility to Chloroquine, Quinine, Monodesethylamodiaquine, Mefloquine, Lumefantrine, and Dihydroartemisinin","author":"N Wurtz","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","first-page":"59","article-title":"Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether\u2013lumefantrine treatment in Mali","volume":"16","author":"S Dama","year":"2017","journal-title":"Malar J. BioMed Central"},{"key":"ref21","article-title":"In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1","author":"L Mwai","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiu358","article-title":"Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT","volume":"210","author":"G Henriques","year":"2014","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.actatropica.2005.06.015","article-title":"Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria","volume":"95","author":"CT Happi","year":"2005","journal-title":"Acta Trop"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/infdis\/jis747","article-title":"Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms","volume":"207","author":"M Malmberg","year":"2013","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/507115","article-title":"Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin","volume":"194","author":"ABS Sidhu","year":"2006","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: Parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine","volume":"91","author":"M Venkatesan","year":"2014","journal-title":"Am J Trop Med Hyg. American Society of Tropical Medicine and Hygiene"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/S2214-109X(16)30236-4","article-title":"Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomise","volume":"5","author":"HM Mavoko","year":"2017","journal-title":"Lancet Glob Heal. Elsevier"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/1745-6215-14-307","article-title":"Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial","volume":"14","author":"H Muhindo Mavoko","year":"2013","journal-title":"Trials"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4269\/ajtmh.2011.11-0071","article-title":"Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy","volume":"85","author":"TT Thomsen","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/infdis\/jir486","article-title":"Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda","volume":"204","author":"FN Baliraine","year":"2011","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4269\/ajtmh.2009.80.555","article-title":"Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo","volume":"80","author":"L Mobula","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref32","article-title":"Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether\u2013lumefantrine drug pressure on Plasmodium falciparum populations in Senegal","author":"A Mbaye","year":"2016","journal-title":"Malar J"},{"key":"ref33","article-title":"The impact of age, temperature, and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda","author":"G Dorsey","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref34","article-title":"Factors contributing to anemia after uncomplicated falciparum malaria","author":"R Price","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064299","article-title":"The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008\u20132011","volume":"8","author":"FL Eyase","year":"2013","journal-title":"PLoS One"},{"key":"ref36","first-page":"344","article-title":"Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children","volume":"210","author":"MD Conrad","year":"2014","journal-title":"J Infect Dis. Oxford University Press"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/AAC.00950-12","article-title":"Assessing the cost-benefit effect of a plasmodium falciparum drug resistance mutation on parasite growth in vitro","volume":"57","author":"G Fr\u00f6berg","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e0151565","DOI":"10.1371\/journal.pone.0151565","article-title":"Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso","volume":"11","author":"P Sondo","year":"2016","journal-title":"PLoS One"},{"key":"ref39","first-page":"10","article-title":"Selection of Plasmodium falciparum Pfmdr-1 N86Y alleles by Amodiaquine-Artesunate and Artemether- Lumefantrine in Nanoro, Burkina Faso","volume":"8","author":"H Tinto","year":"2016","journal-title":"Selection of Plasmodium falciparum Pfmdr-1 N86Y alleles by Amodiaquine-Artesunate and Artemether- Lumefantrine in Nanoro, Burkina Faso"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-3156.2007.01843.x","article-title":"The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa","volume":"12","author":"C Sisowath","year":"2007","journal-title":"Trop Med Int Heal"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1128\/AAC.00012-07","article-title":"Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda","volume":"51","author":"SL Nsobya","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref42","article-title":"Short report: A cross-sectional survey of Plasmodium falciparum pfcrt mutant haplotypes in the Democratic Republic of Congo","author":"AL Antonia","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026005","article-title":"Declining responsiveness of plasmodium falciparum infections to Artemisinin-Based combination treatments on the Kenyan coast","volume":"6","author":"S Borrmann","year":"2011","journal-title":"PLoS One"},{"key":"ref44","article-title":"pfk13-independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemether-lumefantrine in the United Kingdom","author":"CJ Sutherland","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"ref45","first-page":"50","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"FF Ariey","year":"2014","journal-title":"Nature. Nature Publishing Group, a division of Macmillan Publishers Limited"},{"key":"ref46","article-title":"A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms","author":"L Collet","year":"2016","journal-title":"N Engl J Med"},{"key":"ref47","first-page":"1","article-title":"Genomic epidemiology of artemisinin resistant malaria","volume":"5","author":"R Amato","year":"2016","journal-title":"Elife"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","article-title":"Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: An observational cohort study","volume":"15","author":"MD Spring","year":"2015","journal-title":"Lancet Infect Dis. Lancet Publishing Group"},{"key":"ref49","article-title":"Benefits of using multiple first-line therapies against malaria","author":"MF Boni","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"ref50","article-title":"Optimum population-level use of artemisinin combination therapies: A modelling study","author":"TD Nguyen","year":"2015","journal-title":"Lancet Glob Heal"},{"key":"ref51","article-title":"The Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line Therapies","author":"MF Boni","year":"2016","journal-title":"PLoS Med"},{"key":"ref52","article-title":"Artesunate\/amodiaquine versus artemether\/lumefantrine for the treatment of uncomplicated malaria in Uganda: A randomized trial","author":"A Yeka","year":"2016","journal-title":"J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:34:07Z","timestamp":1570667647000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191922"}},"subtitle":[],"editor":[{"given":"David Joseph","family":"Diemert","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191922","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,2,1]]}}}